MOPEB16	Association between HIV-related factors and hypertension and diabetes among people living with HIV in Cameroon	Poster exhibition	Co-morbidities
MOPEB17	Renal safety parameters after switch to doravirine/islatravir (DOR/ISL 100/0.75mg) once-daily: week 48 results from 2 randomized, active-controlled phase 3 trials, MK8591A-017 (P017) and MK8591A-018 (P018)	Poster exhibition	Clinical complications of HIV and antiretroviral therapy
MOPEB18	A randomized controlled trial of (5R)-5-hydroxytriptolide in HIV INRs receiving ART	Poster exhibition	Clinical complications of HIV and antiretroviral therapy
MOPEB19	Weight gain among people living with HIV in Zambia transitioning to dolutegravir-based antiretroviral regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate	Poster exhibition	Clinical complications of HIV and antiretroviral therapy
MOPEB20	Sedative drug burden is associated with concurrent physical frailty in people aging with HIV in Canada: findings from the Positive Brain Health Now Study (+BHN)	Poster exhibition	HIV and ageing
MOPEB21	Disability in people living with HIV (PLWH) in Asia: a prospective multi-centre case-control study	Poster exhibition	HIV and ageing
MOPEC01	Race, place, and substance use continue to impact HIV incidence among Sexual Minority Men: active surveillance of HIV seroconversion from the UNITE Longitudinal Cohort study	Poster exhibition	Epidemiology of HIV
MOPEC02	Demographic and clinical characteristics of mpox among people living with HIV/AIDS (PLWHA) during the 2022 outbreak in Brazil: an observational study	Poster exhibition	Epidemiology of HIV
MOPEC03	Prevalence and correlates of dual mood disorders among PLHIV-PWUD in a Canadian setting	Poster exhibition	Epidemiology of HIV
MOPEC04	Molecular and phylodynamic approaches to the characterisation of HIV-1 transmission: a genomic epidemiological study in Victoria, Australia	Poster exhibition	Surveillance: Measuring the HIV epidemic